154 related articles for article (PubMed ID: 21722969)
1. Canine malignant melanoma alpha-3 integrin binding peptides.
Aina OH; Maeda Y; Harrison M; Zwingenberger AL; Walker NJ; Lam KS; Kent MS
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):11-9. PubMed ID: 21722969
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared optical imaging of ovarian cancer xenografts with novel alpha 3-integrin binding peptide "OA02".
Aina OH; Marik J; Gandour-Edwards R; Lam KS
Mol Imaging; 2005; 4(4):439-47. PubMed ID: 16285906
[TBL] [Abstract][Full Text] [Related]
3. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.
Teixeira TF; Gentile LB; da Silva TC; Mennecier G; Chaible LM; Cogliati B; Roman MA; Gioso MA; Dagli ML
Vet Res Commun; 2014 Mar; 38(1):29-38. PubMed ID: 24126842
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
Smedley RC; Lamoureux J; Sledge DG; Kiupel M
Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Mayayo SL; Prestigio S; Maniscalco L; Rosa G; Aricò A; Maria R; Cavallo F; Ferrone S; Buracco P; Iussich S
Vet J; 2011 Nov; 190(2):e26-e30. PubMed ID: 21482159
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of routine cytology and immunocytochemistry in preoperative diagnosis of oral amelanotic melanomas in dogs.
Przeździecki R; Czopowicz M; Sapierzyński R
Vet Clin Pathol; 2015 Dec; 44(4):597-604. PubMed ID: 26398102
[TBL] [Abstract][Full Text] [Related]
8. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of four canine melanoma cell lines.
Inoue K; Ohashi E; Kadosawa T; Hong SH; Matsunaga S; Mochizuki M; Nishimura R; Sasaki N
J Vet Med Sci; 2004 Nov; 66(11):1437-40. PubMed ID: 15585963
[TBL] [Abstract][Full Text] [Related]
11. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha 3 integrin.
Xiao W; Yao N; Peng L; Liu R; Lam KS
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):94-103. PubMed ID: 18712382
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
Maekawa N; Konnai S; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Takagi S; Kagawa Y; Nakajima C; Suzuki Y; Kato Y; Murata S; Ohashi K
PLoS One; 2016; 11(6):e0157176. PubMed ID: 27276060
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
Segaoula Z; Primot A; Lepretre F; Hedan B; Bouchaert E; Minier K; Marescaux L; Serres F; Galiègue-Zouitina S; André C; Quesnel B; Thuru X; Tierny D
BMC Cancer; 2018 Dec; 18(1):1219. PubMed ID: 30514258
[TBL] [Abstract][Full Text] [Related]
15. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
Choi C; Kusewitt DF
Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
[TBL] [Abstract][Full Text] [Related]
17. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
18. Identification of melanoma-specific exosomal miRNAs as the potential biomarker for canine oral melanoma.
Husna AA; Rahman MM; Lai YC; Chen HW; Hasan MN; Nakagawa T; Miura N
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1062-1073. PubMed ID: 34273912
[TBL] [Abstract][Full Text] [Related]
19. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]